MAP2K7 and neoplasm: EGFR overexpression activates pathways related to proliferation, angiogenesis, cell motility, metastasis, and other tumor-related processes [30,31], and the EGFR pathways associated with cell growth are RAS–RAF–MEK–ERK MAPK and AKT–PI3K–mTOR [29,32].